These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32926386)

  • 1. Profiling Genome-Wide Specificity of CRISPR-Cas9 Using Digenome-Seq.
    Kim D; Kim JS
    Methods Mol Biol; 2021; 2162():233-242. PubMed ID: 32926386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying genome-wide off-target sites of CRISPR RNA-guided nucleases and deaminases with Digenome-seq.
    Kim D; Kang BC; Kim JS
    Nat Protoc; 2021 Feb; 16(2):1170-1192. PubMed ID: 33462439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbiased investigation of specificities of prime editing systems in human cells.
    Kim DY; Moon SB; Ko JH; Kim YS; Kim D
    Nucleic Acids Res; 2020 Oct; 48(18):10576-10589. PubMed ID: 32941652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling Genome-Wide Specificity of dCpf1 Cytidine Base Editors Using Digenome-Seq.
    Kim D
    Methods Mol Biol; 2023; 2606():33-40. PubMed ID: 36592306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq.
    Lazzarotto CR; Nguyen NT; Tang X; Malagon-Lopez J; Guo JA; Aryee MJ; Joung JK; Tsai SQ
    Nat Protoc; 2018 Nov; 13(11):2615-2642. PubMed ID: 30341435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases.
    Huang H; Hu Y; Huang G; Ma S; Feng J; Wang D; Lin Y; Zhou J; Rong Z
    Commun Biol; 2021 Jul; 4(1):830. PubMed ID: 34215845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for Measuring CRISPR/Cas9 DNA Cleavage in Cells.
    Cromwell CR; Jovel J; Hubbard BP
    Methods Mol Biol; 2021; 2162():197-213. PubMed ID: 32926384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq.
    Kim D; Kim S; Kim S; Park J; Kim JS
    Genome Res; 2016 Mar; 26(3):406-15. PubMed ID: 26786045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells.
    Kim D; Bae S; Park J; Kim E; Kim S; Yu HR; Hwang J; Kim JI; Kim JS
    Nat Methods; 2015 Mar; 12(3):237-43, 1 p following 243. PubMed ID: 25664545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency.
    Chung CH; Allen AG; Sullivan NT; Atkins A; Nonnemacher MR; Wigdahl B; Dampier W
    Mol Ther; 2020 Jan; 28(1):19-28. PubMed ID: 31672284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIG-seq: a genome-wide CRISPR off-target profiling method using chromatin DNA.
    Kim D; Kim JS
    Genome Res; 2018 Dec; 28(12):1894-1900. PubMed ID: 30413470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Assays for Comparing the Specificity of First- and Next-Generation CRISPR/Cas9 Systems.
    Cromwell CR; Hubbard BP
    Methods Mol Biol; 2021; 2162():215-232. PubMed ID: 32926385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.
    Malinin NL; Lee G; Lazzarotto CR; Li Y; Zheng Z; Nguyen NT; Liebers M; Topkar VV; Iafrate AJ; Le LP; Aryee MJ; Joung JK; Tsai SQ
    Nat Protoc; 2021 Dec; 16(12):5592-5615. PubMed ID: 34773119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity.
    Lazzarotto CR; Malinin NL; Li Y; Zhang R; Yang Y; Lee G; Cowley E; He Y; Lan X; Jividen K; Katta V; Kolmakova NG; Petersen CT; Qi Q; Strelcov E; Maragh S; Krenciute G; Ma J; Cheng Y; Tsai SQ
    Nat Biotechnol; 2020 Nov; 38(11):1317-1327. PubMed ID: 32541958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off- and on-target effects of genome editing in mouse embryos.
    Ayabe S; Nakashima K; Yoshiki A
    J Reprod Dev; 2019 Feb; 65(1):1-5. PubMed ID: 30518723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor.
    Kwon J; Kim M; Bae S; Jo A; Kim Y; Lee JK
    Nat Commun; 2022 Dec; 13(1):7975. PubMed ID: 36581624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide identification and analysis of highly specific CRISPR/Cas9 editing sites in pepper (Capsicum annuum L.).
    Li G; Zhou Z; Liang L; Song Z; Hu Y; Cui J; Chen W; Hu K; Cheng J
    PLoS One; 2020; 15(12):e0244515. PubMed ID: 33373406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of CRISPR/Cas9 Off-Target Activity in Hematopoietic Stem and Progenitor Cells.
    Park SH; Lee CM; Bao G
    Methods Mol Biol; 2022; 2429():281-306. PubMed ID: 35507169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.